Contact Us

Get 30% Free Customization on This Report

Published Date: July, 2019

Biopharmaceutical Fermentation Systems Market (Product - Upstream Process Product, and Downstream Process Products; Application - Antibiotics, Monoclonal Antibodies, Recombinant Proteins, Probiotics, and Other Applications; End User - Biopharmaceutical Companies, Contract Research Organizations, Research and Development Institutes, Food Industry, and Other End Users): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025


Request Discount Enquire Before Buying

A recent report published by Infinium Global Research on biopharmaceutical fermentation systems market provides in-depth analysis of segments and sub-segments in the global as well as regional biopharmaceutical fermentation systems market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional biopharmaceutical fermentation systems market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global biopharmaceutical fermentation systems market. According to the report, the global biopharmaceutical fermentation systems market is projected to grow at a CAGR of 5.8% over the forecast period of 2019-2025.

Market Insight

Biopharmaceutical fermentation systems market is anticipated to witness healthy growth in the forecast period. Biopharmaceutical fermentation systems are used to produce recombinant genetic products for therapeutic purposes (TPA, interferon, insulin, h-Factor VII), growth hormones and enzymes in large scale. The high demand for biopharmaceuticals is likely to propel the demand for biopharmaceutical fermentation systems globally.

Increasing demand of biotech-based drugs is one of the major factor driving the growth of biopharmaceutical fermentation systems market. Increasing global population with a number of genetic disorders and deficiencies has increased the demand for recombinant drugs or biopharmaceuticals such as proteins, enzymes, etc., that in turn has boosted the demand of biopharmaceutical fermentation systems. Moreover, rising research and development activities to produce novel biological drugs has propelled the demand for biopharmaceutical fermentation systems. Major Pharma companies are investing a huge amount in research and developments sector as well as biological manufacturing plants to meet the global demand of biopharmaceuticals, additionally government institutes are also investing the major share of healthcare expenditure on the production of biological drugs, all these factors are combined contributions to the growth of biopharmaceutical fermentation systems market. On the other hand, the high cost associated with the bioreactors and its installation can hamper the growth of the market. However, new innovation to make efficient and cost-effective fermentation systems to make it feasible for small scale industries can provide better opportunities for the market.

Geographically, Global biopharmaceutical fermentation systems market segmented into North America, Europe, Asia-Pacific, and Row. North America dominates the market in terms of revenue generation followed by Europe. Well established healthcare infrastructure, presence of key players and rising industrialization are some factors contributing to the growth of these regions. The Asia Pacific is anticipated to grow with high rate in the forecast period, large patient pool, rising demand of biological drugs and developing healthcare industries in countries such India, China and Japan will contribute for the growth of the region in near future.

Segment Covered

The report on global biopharmaceutical fermentation systems market covers segments such as product, application, and end user. On the basis of product, the sub-markets include upstream process product, and downstream process products. On the basis of application, the sub-markets include antibiotics, monoclonal antibodies, recombinant proteins, probiotics, and other application. On the basis of end user, the sub-markets include biopharmaceutical companies, contract research organizations, research and development institutes, food industry, and other end users. 

Companies Profiled:

The report provides profiles of the companies in the market such as Merck KGaA, Sartorius Stedim, Thermo Fisher Scientific, GE Healthcare, Nova Biomedicals, Becton, Dickinson and Company, Lonza, Danaher Corporation, F. Hoffmann-La Roche Ltd, and Other companies. 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of biopharmaceutical fermentation systems market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

1.     Preface

1.1.   Report Description

1.2.   Research Methods

1.3.   Research Approaches

 

2.     Executive Summary

2.1.   Biopharmaceutical Fermentation Systems Market Highlights

2.2.   Biopharmaceutical Fermentation Systems Market Projection

2.3.   Biopharmaceutical Fermentation Systems Market Regional Highlights

 

3.     Global Biopharmaceutical Fermentation Systems Market Overview

3.1.   Introduction

3.2.   Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3.   Porter's Five Forces Analysis

3.4.   IGR-Growth Matrix Analysis

3.4.1. IGR-Growth Matrix Analysis by Product

3.4.2. IGR-Growth Matrix Analysis by Application

3.4.3. IGR-Growth Matrix Analysis by End User

3.4.4. IGR-Growth Matrix Analysis by Region

3.5.   Value Chain Analysis of Biopharmaceutical Fermentation Systems Market

 

4.     Biopharmaceutical Fermentation Systems Market Macro Indicator Analysis

 

5.     Global Biopharmaceutical Fermentation Systems Market by Product

5.1.   Upstream Process Product

5.1.1.  Bioreactors/Fermenters

5.1.2.  Process Monitoring Systems

5.1.3.  Media and Culture Preparation

5.1.4.  Buffers

5.1.5.  Other Upstream Products

5.2.   Downstream Process Products

5.2.1.  Filtration and Separation Instruments

5.2.2.  Chromatography Systems

5.2.3.  Consumables and Accessories

5.2.4.  Other Downstream Products

 

6.     Global Biopharmaceutical Fermentation Systems Market by Application

6.1.   Antibiotics

6.2.   Monoclonal Antibodies

6.3.   Recombinant Proteins

6.4.   Probiotics

6.5.   Other Applications

 

7.     Global Biopharmaceutical Fermentation Systems Market by End User

7.1.   Biopharmaceutical Companies

7.2.   Contract Research Organizations

7.3.   Research and Development Institutes

7.4.   Food Industry

7.5.   Other End Users

 

8.     Global Biopharmaceutical Fermentation Systems Market by Region 2019-2025

8.1.   North America

8.1.1. North America Biopharmaceutical Fermentation Systems Market by Product

8.1.2. North America Biopharmaceutical Fermentation Systems Market by Application

8.1.3. North America Biopharmaceutical Fermentation Systems Market by End User

8.1.4. North America Biopharmaceutical Fermentation Systems Market by Country

8.2.   Europe

8.2.1. Europe Biopharmaceutical Fermentation Systems Market by Product

8.2.2. Europe Biopharmaceutical Fermentation Systems Market by Application

8.2.3. Europe Biopharmaceutical Fermentation Systems Market by End User

8.2.4. Europe Biopharmaceutical Fermentation Systems Market by Country

8.3.   Asia-Pacific

8.3.1. Asia-Pacific Biopharmaceutical Fermentation Systems Market by Product

8.3.2. Asia-Pacific Biopharmaceutical Fermentation Systems Market by Application

8.3.3. Asia-Pacific Biopharmaceutical Fermentation Systems Market by End User

8.3.4. Asia-Pacific Biopharmaceutical Fermentation Systems Market by Country

8.4.   RoW

8.4.1. RoW Biopharmaceutical Fermentation Systems Market by Product

8.4.2. RoW Biopharmaceutical Fermentation Systems Market by Application

8.4.3. RoW Biopharmaceutical Fermentation Systems Market by End User

8.4.4. RoW Biopharmaceutical Fermentation Systems Market by Sub-region

 

9.     Company Profiles and Competitive Landscape

9.1.   Competitive Landscape in the Global Biopharmaceutical Fermentation Systems Market

9.2.   Companies Profiles

9.2.1. Merck KGaA

9.2.2. Sartorius Stedim

9.2.3. Thermo Fisher Scientific

9.2.4. GE Healthcare

9.2.5. Nova Biomedicals

9.2.6. Becton

9.2.7. Dickinson and Company

9.2.8. Lonza

9.2.9. Danaher Corporation

9.2.10.   F. Hoffmann-La Roche Ltd

9.2.11.   Other companies

 

10.  Appendix

10.1.  Primary Research Findings and Questionnaire

Request Detailed TOC


Note: Please input above shown text into input box

The Infinium Advantages

Analyst Support

Get free analyst support for the queries before and post purchasing report.

Customer Satisfaction

Be assured of 100% customer satisfaction about the research and get 24X7 customer support.

400% Growth

Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.

sign up for our newsletter